Nutrients, Vitamins & Cancer
- Vitamin C
– High Intravenous Dose
- Vitamin D
- Vitamin B17,
Amygdalin & Laetrile
- Folic Acid and
Folate Vitamin B9
- Inositol &
IP-6 (Inositol Hexaphosphate)
(I3C) & Isocyanates
Zinc, Pumpkin Seeds, Prostatol,
Prostate Care, etc.
- Iron Overload
- Soy Products,
Fermented Soy Extracts, Haelan 951, Soy Essence,
Nutra-Soy, Soy Option, EcoGen, etc.
Vegetable and Fruit Juices
- Ellagic Acid
Fibre and Sodium Butyrate
(Turmeric / Haldi)
Linoleic Acid (CLA)
Citrus Pectin (MCP)
Proprietary Product Options
Flavopereirine, Sempervirine, Serpentine, Pao Pereira, Rauwolfia,
Ginko biloba & the Work of Mirko Beljanski
C-Statin & Imm-Kine
A Ginseng Extract
& Shark Cartilage
Mineral & Chemical Options
Chloride High pH Therapy
Natural Cellular Defense
Particular Therapeutic Options
Dendritic Cell Vaccines
Fuad Lechin's Method of Neuroimmunomodulation
Aromatherapy, Polarity Therapy, Therapeutic Massage,
Everyone knows that exercise is required to maintain a healthy body,
but few people are aware of the extensive research demonstrating
a specific preventative link between exercise, cancer and other
illnesses. There is no doubt that regular exercise gives you more
energy, makes you feel better, lowers your stress levels, and helps
prevent ill health. The physiological effects of regular exercise
News Report – “Exercise 'halves cancer risk’.”
of Minnesota Cancer Center – “Cancer Risk Reduction: Exercise
Cancer Society – Some excellent suggestions on staying active,
fitting in fitness, and making exercise work for you.
Cancer Society – “Exercise to Stay Active: Find out how much
activity is healthy during treatment and create an exercise program
that's right for you.”
– “Exercise as cancer treatment.”
– A useful article relating exercise to specific forms of cancer
on Dr Joseph Mercola's nutritional supplement shop and health information
Wire – Reports on “a survey commissioned by the American Institute for Cancer Research (AICR) revealing
that a high percentage of Americans are unaware that regular exercise
can reduce the risk of cancer. In contrast, the great majority know
that eating vegetables and fruit can contribute to the body's defense
against the disease.”
Cancer Vaccines &
Dendritic Cell Vaccines
The possibility of creating cancer vaccines has arisen from observations
that even advanced cancers are sometimes reduced or even completely
disappear when the patient suffers a viral or bacterial infection.
It is presumed that when the infection stimulates the patient's
immune system, the cancer also gets zapped. Cancer vaccines (containing
tumour cells or antigens) seek to stimulate the patient’s immune
system into producing T-cell lymphocytes, which destroy cancer cells,
and prevent relapses of the cancer. Unlike other vaccines, cancer
vaccines cannot be used preventatively, but only to attack existing
cancers. Vaccines are prepared in a number of ways, sometimes from
breakdown products of cancer cells found in the patient’s urine.
“Dendritic cells are professional antigen-capturing
and -presenting cells of the immune system. Because of their exceptional
capability of activating tumor-specific T-cells, cancer vaccination
research is now shifting toward the formulation of a clinical human
dendritic cell vaccine.” (Peter Ponsaerts et. al)
– “How Cancer Vaccines will Work.” A short and clear overview.
– “Provenge – Dendritic cell vaccine for Prostate Cancer.” A short
Clinic – “Dendritic Cell Therapy Vaccines: A Promising
New Approach to the Treatment of Cancer.” A readable technical overview
by Dr Julian Kenyon.
Clinic – An observation study by Dr Julian Kenyon of 32 consecutive
cancer patients who were given dendritic cell vaccine.
Dove Clinic – Home
page of Dr Julian Kenyon’s UK integrated medicine clinic in Winchester
and London, where dendritic cell vaccines are used, together with
other therapies and diagnostic tools.
Photodynamic therapy, also called photochemotherapy, phototherapy,
or photoradiation therapy, is based on the discovery that cells
or organisms treated with a photosensitizing agent can then be destroyed
by means of light. PDT involves the use of a photosensitizing drug,
which is either applied to the skin or injected intravenously. After
a two or three days, when the drug has been absorbed throughout
the body, though more selectively in cancer cells, a low-level,
fixed-frequency laser light is focused on the tumour, causing the
drug to react with oxygen. This forms free radicals or other substances
which kill the cancer cells, or destroys the blood vessels that
feed the cancer cells. PDT may also trigger the immune system to
attack the cancer cells. The actual laser treatment can take between
5 to 40 minutes, depending on the area being treated.
Since PDT is only useful for treating tumours or pre-cancerous tissues
where laser light can reach, it is not always practical. This usually
restricts PDT to areas on or lying no more that half an inch beneath
the skin, or in the accessible lining of internal organs, especially
the larynx, oesophagus, lungs, stomach, colon, rectum, and bladder.
Treatment of prostate, ovarian and pancreatic cancers are still
in an experimental stage. Large tumours are more difficult to treat
with PDT because the light does not penetrate deeply enough.
In cases where PDT can be used, studies have shown it to be as effective
as surgery or radiation therapy. The advantages are that the patient
does not have to undergo surgery; the cancer can be very precisely
targeted; the treatment can be repeated on the same site (unlike
radiation); and the patient can generally be treated as an outpatient.
The major drawback with some PDT drugs is that because they spread
throughout the body, the skin and eyes become very sensitive to
bright light for up to six weeks, even up to 90 days, requiring
special precautions. PDT can also cause burns, swellings or pain
in nearby tissue. Depending on the area treated, PDT can also result
in coughing, swallowing difficulty, stomach pain, painful breathing,
and shortness of breath.
A small number of photosensitizing agents are used, notably Photofrin
Kerastick. Other more advanced agents include Photoflora, a
chlorophyll extract which is taken orally, accumulates selectively
in tumours, does not persist in the skin, and lasts only 24 to 48
hours in the body, resulting in minimal post-therapy photosensitivity.
Systemic Light Therapy, a variant of PDT, uses the experimental
Russian photosensitizing agent and chlorophyll derivative, Radachlorin.
This too persists in the body for a few days only.
Current advances in PDT are exploring the use of photosensitizing
agents that are more selectively absorbed by and collect more rapidly
in cancer cells, and can be removed more quickly from the body.
Other research is focusing on the use of fibre optics to deliver
laser beams to tumours deep inside the body.
Cancer Center (University of Pennsylvania) A brief overview.
A more detailed overview can be found on their Oncolink
Backup An excellent overview of all aspects of PDT.
Cancer Institute A reasonably detailed overview.
Cancer Society An overview of the future of PDT.
NZ An overview, also listing a number of potential photosensitizing
Clinic Next Generation PDT. An excellent,
cutting-edge article from UK cancer specialist, Dr Julian Kenyon,
who uses an advanced chorophyll extract in his PDT.
of Life Dr Michael Tait's cancer clinic in Queensland,
Australia, offering PDT, which uses a chlorophyll extract photosensitizer
similar to Radachlorin.
Appleseed Project A Dutch patient reports his experiences
with Systemic Light Therapy, using Radachlorin.
The manufacturer of Radachlorin, also called Photolife.
Medical Laser Center Information regarding PDT for lung
cancer patients, from a cancer treatment center in Oregon.
Park Cancer Institute A US cancer treatment centre in
Buffalo, New York, offering PDT.
Cancer Survival Center A centre offering PDT at clinics
in Knoxville and Oak Ridge, Tennessee, USA.
Lechin's Method of Neuroimmunomodulation
Dr Fuad Lechin (b. 1928) is an eminent and internationally respected
Venezuelan professor and Nobel prize nominee, head of the departments
of neuropharmacology, neurochemistry and stress, at the Institute
of Experimental Medicine, Central University of Venezuela in Caracas.
His main field of research has been that of the neuroendocrine and
bodily immune systems. His laboratory has profiled the neurochemistry
and immunological status of over 25,000 normal and diseased people.
Dr Lechin's approach to treating cancer is first to profile the
immunological responsivity of a person's main neurotransmitters
(chiefly noradrenaline, adrenaline, dopamine, serotonin, and tryptophane),
together with other immune system and biological markers. These
are assayed from blood serum, rather than urine samples. The therapy
involves fine tuning this profile towards that of a healthy person.
His system is non-toxic, and can be integrated with other non-toxic
treatments. Although he has lectured widely on his research, and
oncologists have been very interested in his work, they have found
it difficult to implement his methods. Hospitals generally want
easily administered package treatments, like chemotherapy or radiotherapy,
where there is very little variation between the treatment given
to individual patients. To monitor and manipulate individual neurotransmitters
requires considerable skill and experience, as well as access to
appropriate neurochemical laboratory facilities. The absence of
both the skilled experience, as well as the necessary facilities
in most hospitals makes Dr Lechin's system difficult to implement.
Consequently, patients are currently treated at his centre in Caracas,
where around 3000 patients have so far been seen. He has published
several clinical studies of his work, demonstrating either tumour
remission, or a reduction, slowing, or complete halt to the progression
of metastases. All patients in these studies have shown a significant
increase in life expectancy.
Dr Lechin has also successfully applied the same therapeutic techniques
to other illnesses, including rheumatoid arthritis, multiple sclerosis,
bipolar syndrome, myasthenia gravis, thrombocytopenic pupura, Guillain-Barre
syndrome, Crohn's disease, and other conditions related to immunological
dysfunction. It is likely that a detailed understanding of and the
ability to fine tune the body's immune system will be of great significance
in the treatment of many diseases in the decades ahead. Dr Lechin
in the author of over 170 research papers and several books.
Dr Fuad Lechin
Cancer An extract from the book, Healing Cancer,
concerning Dr Lechin's approach to cancer treatment, including details
of treatment cost, staying at his clinic in Caracas, and so on.
Over 90 of Dr Lechin's published papers can be accessed by
searching for Lechin F'.
of Applied Research Two case studies.
The story of Dr Stanislav Burzynski's novel treatment for cancer
is a confused trail, further confounded by the fact that much of
the information on the internet is out of date. Without going into
the history, the current status seems to be that Dr Burzynski is
using two anti-cancer drugs, designated antineoplastons Aminocare
A10 and AS2-1, which seem to have a particular efficacy against
brain cancer and non-Hodgkins lymphoma. Some studies and anecdotal
evidence, however, suggest that they may be of use in combating
other forms of cancer. Many of Dr Burzynski's patients claim that
their cancers have been cured or held in a stable condition as a
result of his treatment.
is known as a 'neoplasm' (a new formation). Anti-cancer compounds
can therefore be called 'antoneoplastons'.
antineoplastons are peptides, small proteins or amino-acid chains,
found in normal human blood. In cancer patients, however, antineoplaston
levels tend to be low as little as 2% of that of healthy
individuals. In normally functioning tissues and organs, cells die
and are replaced on a regular basis. Cancer cells, on the other
hand, go on living and proliferating because the system that induces
programmed cell death (apoptosis) is switched off. Antineoplastons
work by 'reprogramming' cancer cells to die like normal cells, while
healthy cells remain unaffected.
Antineoplastons function in two ways. They suppress the activity
of the oncogenes that cause the endless proliferation of cancer
cells, and at the same time stimulate the activity of the tumor-suppressor
genes that instruct cells to die normally. Normal chemotherapy agents
are designed to catch and kill cells during their division phase.
In the process, they also kill vast numbers of normal cells, resulting
in well-known side effects. Instead of killing cancer cells, antineoplastons
reprogramme them to die in the normal manner.
Personalised treatment is available at Dr Burzynski's clinic in
Houston, Texas, and costs around $2000 a month. Though no substitute
for his complete therapy, aminocare products can also be purchased
as nutritional supplements for independent use. Sales of aminocare
products help support the FDA-supervised clinical trials of Dr Burzynski's
with Dr Burzynski May 2003. One of the best sources of
reasonably up-to-date information.
Education Alliance for Life and Longevity A brief overview
Directory of Minnesota
A brief history and overview, with a review
of Aminocare products.
Cancer Institute Report on antineoplastons.
Dr Burzynski's website.
Research Institute Details the research and FDA-supervised
Patient Group A support group, with many individual stories.
Dr Burzynski's Aminocare sales site.
Alexander One family's story of a child with a brain
Project Susan Zimmerman's story of controlling breast
of Dr Burzynski's theory of aging through the methylation of DNA.
Interface RNA Resources
Gene Silencing or Gene Activation? by S.R.
Burzynski. A scientific presentation of his hypothesis.
Based on research indicating that radiowaves can influence cell
division, Dr John Holt, an Australian radiologist from Perth, introduced
his first form of radiowave treatment for cancer during the 1970s.
His final form of treatment, introduced in the late 1990s was based
on his discovery that 434 MHz ultrahigh frequency radiowaves stimulate
cancer cells to divide more rapidly.
In order to divide and perform their various functions, all cells
require energy. Usually, this is provided by the 'burning' of glucose.
To do this, normal cells generally use oxygen, but for reasons that
are not entirely understood, cancer cells burn glucose in the absence
of oxygen (glycolysis).
If, therefore, cancer cells are stimulated to divide more rapidly
by exposure to 434 MHz radiowaves (hence requiring more glucose),
and at the same time their glucose supply is blocked, they will
be starved of their energy supply, and will die. The blocking is
achieved by use of a 'glycolytic blocking agent' (GBA), which is
injected into the patient immediately prior to and during exposure
to 434 MHz radiowaves. The more rapidly the cancer cells are trying
to divide at the time of treatment, the more effective it is. According
to Dr Holt, the GBA acts only on cancer cells, is not harmful, and
is cleared from the body within 24 hours.
To give the patient the best chance of response, the treatment is
repeated for about an hour a day over a three week period. Like
all cancer treatments, it is uncertain how well radiowave therapy
will work in individual cases, or whether it will work at all. Not
all cancers are suitable for radiowave therapy, and patients are
screened before admission into treatment. Influencing factors include
the type of cancer, its invasiveness and total size, the amount
of previous chemotherapy, and the patient's mobility and state of
health. Since patients are required to eat red meat five times a
week during treatment, it is also unsuitable for vegetarians. Radiowave
therapy is different from microwave or hyperthermia (heat) treatment,
where the intention is to heat the cancer cells until they die.
Dr Holt retired in 2005, at the age of 80. Although the National
Health and Medical Research Council (NHMRC) produced a negative
report concerning the efficacy of his treatment, the reality is
that there is insufficient evidence, according to strict scientific
protocols, to decide whether or not it is effective. It is for this
reason that the Radiowave Therapy Research Institute has been founded
both to treat patients and to conduct clinical trials. Nevertheless,
there are a significant number of patients who are now alive and
well, free from cancer, after receiving treatment from Dr Holt.
In the scientific and medical world, however, such anecdotal evidence
is unacceptable as proof, because the full circumstances are unknown.
Dr Holt's treatment and research is also being continued by Dr Hugh
Tinsley and Victor Thorne, at the Rose Lodge Clinic, at Kilternan
in Ireland, in conjunction with Dr Max Ammann and Dr James Murpy
of the Dublin Institute of Technology. A modified form of Dr Holt's
therapy is practised by ex-dentist, Noel Campbell, at the Australian
Hope Clinic for Integrated Western, Alternate and Complementary
Therapy Research Institute A privately funded institute
in Perth, to whom Dr Holt is scientific advisor, providing radiowave
therapy and acting as a focal point for interested parties. Includes
history and overview of the treatment and research programme,
with costs, together with the aims of the institute.
Support Free support group, presently offering a monthly
Hope Clinic for Integrated Western, Alternate and Complementary
Medicine An overview from a Melbourne clinic offering
a modified form of Dr Hope's radiowave therapy.
Institute of Technology Report of a visit by Dr John
Holt, to see and discuss their research. There is also the report
of a visit by Tom Kitt (minister of state in the Department
of the Taoiseach and government chief whip) and photos of Dr
Tinsley's clinic. This clinic can be contacted through the London
cancer charity, Yes
Health and Medical Research Council (NHMRC) Media release,
with summary of the full
report on Dr John Holt's radiowave therapy.
Up A pithy article from TV presenter Ray Martin (who
is generally anti-alternatives), regarding the NHMRC report, also
relating some of the anecdotal evidence in favour of Dr Holts therapy.
Top Secret News Network (ATSNN) A collection of opinions
regarding Dr Holt and the NHMRC report.
Ninemsn News reports concerning Dr Holt's work.
and Optical Technology Letters Investigation of
the Near-field Behaviour and SAR for the Resonant Loop Antenna Operating
at 434 MHz for Medical Applications (2005). A research paper from the Dublin group.
is one billionth of a metre 1/80,000th the diameter of a
human hair, and about as wide as ten hydrogen atoms. Nanotechnology
is the use of materials less than 100 nanometres in size. The field
includes physicists, chemists, biologists, and engineers. In October
2004, the US National Cancer Institute announced their own initiative,
Alliance for Nanotechnology in Cancer, with funding of $144.3
million over five years.
Animal cell sizes are around 10,000 to 20,000 nanometres. Haemoglobin,
the large molecule that carries oxygen in the blood, is around 5
nanometres. Nanoscale devices less than 50 nanometres can enter
cells and interact with DNA, large proteins and other minute cell
structures. Those less than 20 nanometres can move out of blood
vessels into the surrounding tissues. Current nanotool research
includes the detection of molecular changes associated with cancer,
help with imaging and an accurate diagnosis, delivery of anti-cancer
agents to cancer cells, and monitoring of the results. It is hoped
that the first clinical nanotools for use with cancer will be available
in 15 years.
Research at Stanford University, for example, has shown that cancer
cells injected with carbon nanotubes and then irradiated with near-infrared
laser light, heat up, causing their death. Near-infrared light passes
safely through normal cells. Cancer cells are covered with receptors
for the B vitamin, folate. The nanotubes were delivered selectively
to cancer cells by coating them with folate, enabling them to pass
easily into the cancer cells. Similarly, the researchers hope that
it will be possible to attach cancer antibodies to nanotubes, making
them specific to particular form of cancer. They are presently working
on a way of targeting lymphoma in mice.
An international team of researchers have developed a method of
labelling specific molecules with a nanoscale marker particle, which
then fluoresces when irradiated with light in the red to ultraviolet
Cancer Institute A general overview. The NCI also provides
a more in-depth
News A news report on the nanotube research at Stanford
for International Cancer Research A report on the nanoparticle
labelling of specific molecules.
What has become known as integrated medicine is practised by a relatively
small number of qualified medical practitioners worldwide who are
not only aware of the latest developments in medical science, but
have also qualified in many other fields of complementary medicine,
including nutrition, homoeopathy, acupuncture, Chinese herbal medicine,
traditional herbal medicine, etc. Such practitioners seek to open-mindedly
combine the best of all approaches.
Doctors and Clinics Worldwide – A useful list, including
doctors and clinics in the UK, USA, etc.
Cancer Cure Foundation Clinics outside the US offering
complementary or alternative cancer treatments, including Dr
Etienne Callebout, who practices integrated medicine in London,
Centre for Natural Healing
– A wholistic healthcare clinic in Ashland, Oregon, with expertise
and experience in cancer treatment, with an emphasis on a herbal
and nutritional approach, also extending to other therapeutic techniques.
Telephone consultations available, worldwide.
Dove Clinic – Home page of Dr Julian Kenyon’s UK integrated medicine clinic in Winchester
and London, where dendritic cell vaccines and medicinal mushrooms
are used, together with other therapies and diagnostic tools.
Fountain of Life Dr Tait's alternative cancer clinic
in Queensland, Australia, offering Ukrain, Avemar, PDT, immune response
therapy, intravaneous hydrogen peroxide, intravenous vitamic C,
inhaled glutathione therapy, laetrile (vitamin B17), and chelation
Cancer Clinic A cancer clinic at Freeport, in the Bahamas,
offering a variety of alternative cancer treatments, including immuno-boosting,
anti-angiogenesis and anti-wasting therapies, cancer vaccines, and
Sanoviv Medical Institute – A luxury hospital and health
centre in Mexico, blending both holistic and modern medicine.
– A US clinic based on the idea of 'cooperative medicine', where
teams of experts combine their skills and experience to help solve
people's medical problems. Centres in Arizona, Florida & Minnesota.
Yes To Life – An excellent UK site with a balanced viewpoint, seeking to provide
clear information on the best complementary treatments available
to cancer patients. Also working to bring such treatments within
the orbit of the UK's NHS.
There are a number of homoeopathic remedies that can help in a cancer
situation – either to encourage post-operative healing, or to help
reduce the side effects of chemotherapy or radiotherapy, or to try
and deal with the cancer itself. However, homoeopathic remedies
are best prescribed for an individual by a suitably qualified homoeopath.
To find the best homoeopathy sites do internet searches on “homoeopathy”
(British spelling) and “homeopathy” (US spelling).
Good practitioners of these therapies can help
balance the body’s subtle energy system, optimizing the effect
of an individual’s own natural defences. Doing an internet search
for a particular therapy will normally result in the main colleges
and regulatory bodies being near the top of the search results.
It’s better for you to do your own search, since you’ll need to
find someone in your own area. You could also ask for a recommendation
in a local wholefood shop or from friends.
Davidson, 2006, 2008
& Domains by Kalden
Logo by SeanDesign